Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS

Showing 15 posts of 1081 posts found.

merckwindow_web

Scotland approves first-line NHS use of MSD’s Keytruda combo for advanced non-small cell lung cancer

October 7, 2019
Sales and Marketing Cancer, NHS, Scotland, Scottish Medicines Consortium, UK, keytruda, lung cancer, pharma

The Scottish Medicines Consortium (SMC) has announced its decision to accept MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) in combination with pemetrexed …

News

NICE recommends Takeda’s Takhzyro for NHS use to prevent hereditary angioedema attacks

September 18, 2019
Research and Development, Sales and Marketing NHS, NICE, Takeda, Takhzyro, pharma

UK drug watchdog NICE has announced its final draft guidance recommending Takeda’s subcutaneous injection Takhzyro (Lanadelumab) for use on the …

News

NICE recommends Novartis’ gene therapy Luxturna for inherited retinal dystrophy

September 4, 2019
Research and Development, Sales and Marketing Luxturna, NHS, NICE, UK, gene therapy, pharma

NICE has chosen to recommend the use of Novartis’ one-time gene therapy Luxturna (voretigene neparvovec) for use on the NHS …

News
brexit_flag

No-deal Brexit will “make the disintegration of the health service an ever more real prospect”, BMA warns

September 2, 2019
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMA, NHS, UK, brexit, pharma

As the UK hurtles towards a catastrophic and autocratic exit from the European Union, the British Medical Association (BMA) has …

News
andrew_dillon

NICE Chief Sir Andrew Dillon to step down in 2020

August 22, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK pharma, UK< pharma

It’s the end of an era at the National Institute of Health and Care Excellence (NICE), the UK watchdog responsible …

News
cannabis-2152604_960_720

Hundreds of patients turn to private cannabis clinics in UK

August 16, 2019
Medical Communications Marijuana, NHS, UK, cannabis, medicinal cannabis, pharma

Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …

News

Aspen Pharmacare to pay £8 million after colluding to rip off NHS

August 14, 2019
Research and Development Addison's disease, Aspen Pharmacare, CMA, NHS, pharma

South African firm Aspen Pharmacare has agreed to pay £8 million to Britain’s NHS over a dispute about overpayment. The …

News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Camurus’ weekly/monthly opioid dependence injection accepted in Scotland for NHS use

August 13, 2019
Manufacturing and Production, Sales and Marketing Camurus, NHS, Scotland, nhs scotland, opioid dependence, opioids, pharma

The Scottish Medicines Consortium (SMC) has announced its acceptance of Buvidal (buprenorphine prolonged-release solution for subcutaneous injection) from Swedish pharma …

News
merck-keytruda

Keytruda/chemo combo recommended for first-line lung cancer via Cancer Drugs Fund

August 8, 2019
Sales and Marketing CDF, Cancer, MSD, NHS, NICE, UK, keytruda, lung cancer, pharma

MSD’s Keytruda (pembrolizumab) has secured recommendation from NICE for inclusion on the Cancer Drugs Fund (CDF) in combination with chemotherapy …

News

NICE recommends Pierre Fabre’s Nerlynx in adjuvant HER2+ breast cancer

August 7, 2019
Research and Development, Sales and Marketing Cancer, NCIE, NHS, Nerlynx, Pierre Fabre, UK, breast cancer

Pierre Fabre’s Nerlynx (neratinib) has been recommended by NICE as a new option for NHS patients with early hormone-receptor-positive, human …

News
nice_new_london_office_internal_2_8

NICE reject Clovis Oncology’s ovarian cancer drug Rubraca

August 6, 2019
Manufacturing and Production NHS, NICE, Rubraca, UK, guidance, pharma

Britain’s cost-effectiveness body NICE has chosen not to recommend Clovis Oncology’s cancer drug Rubraca (rucaparib). On 6 August, NICE issued …

News
shutterstock_141299494

Top UK doctors warn Boris Johnson that no-deal Brexit would cause key cancer therapy supply shortages

August 2, 2019
Manufacturing and Production, Medical Communications Cancer, NHS, UK, brexit, pharma

Top doctors from some of the UK’s foremost nuclear medicine associations have written a letter to recently-anointed Prime Minister Boris …

News

Bayer’s Xarelto combo greenlighted by NICE for reducing CV events in artery disease

August 1, 2019
Sales and Marketing NHS, NICE, UK, Xarelto, cardiovascular disease, pharma

NICE has awarded final appraisal recommendation to Bayer’s Xarelto (rivaroxaban) at a dosage of 2.5mg twice daily in combination with …

News
survey-2316468_640

The patient is always right: Extracting the full value of PROMs

July 29, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PROs, UK, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes …

Feature

AstraZeneca’s Lynparza approved via Cancer Drugs Fund for BRCA+ gynaecological cancers

July 26, 2019
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Cancer Drugs Fund, NHS, NICE, UK, lynparza, pharma

NICE has published final guidance which approves AstraZeneca’s Lynparza (olaparib) for use on the NHS as a maintenance therapy for …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024